Patents by Inventor Sami N. Malek

Sami N. Malek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS
    Publication number: 20210161991
    Abstract: The present invention relates to treating a hematologic cancer using a Hypoxia-Inducible Factor (HIF inhibitor). The invention also relates to inducing acute myeloid leukemia remission using the HIF inhibitor. The invention further relates to inhibiting a maintenance or survival function of a cancer stem cell (CSC) using the HIF inhibitor.
    Type: Application
    Filed: October 13, 2020
    Publication date: June 3, 2021
    Applicant: OncoImmune, Inc.
    Inventors: Yang LIU, Yin WANG, Yan LIU, Sami N. MALEK, Pan ZHENG
  • USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS
    Publication number: 20200147167
    Abstract: The present invention relates to treating a hematologic cancer using a Hypoxia-Inducible Factor (HIF inhibitor). The invention also relates to inducing acute myeloid leukemia remission using the HIF inhibitor. The invention further relates to inhibiting a maintenance or survival function of a cancer stem cell (CSC) using the HIF inhibitor.
    Type: Application
    Filed: January 21, 2020
    Publication date: May 14, 2020
    Applicant: OncoImmune, Inc.
    Inventors: Yang LIU, Yin Wang, Yan Liu, Sami N. Malek, Pan Zheng
  • USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS
    Publication number: 20190255140
    Abstract: The present invention relates to treating, a hematologic cancer using a Hypoxia-Inducible Factor (HIF inhibitor). The invention also relates to inducing acute myeloid leukemia remission using the HIT inhibitor. The invention further relates to inhibiting a maintenance or survival function of a cancer stem cell (CSC) using the HIE inhibitor.
    Type: Application
    Filed: March 6, 2019
    Publication date: August 22, 2019
    Applicant: OncoImmune, Inc.
    Inventors: Yang Liu, Yin Wang, Yan Liu, Sami N. Malek, Pan Zheng
  • USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS
    Publication number: 20180177841
    Abstract: The present invention relates to treating a hematologic cancer using a Hypoxia-Inducible Factor (HIF inhibitor). The invention also relates to inducing acute myeloid leukemia remission using the HIF inhibitor. The invention further relates to inhibiting a maintenance or survival function of a cancer stem cell (CSC) using the HIF inhibitor.
    Type: Application
    Filed: December 12, 2017
    Publication date: June 28, 2018
    Applicant: OncoImmune, Inc.
    Inventors: Yang Liu, Yin Wang, Yan Liu, Sami N. Malek, Pan Zheng
  • Uses of hypoxia-inducible factor inhibitors
    Patent number: 9877998
    Abstract: The present invention relates to treating a hematologic cancer using a Hypoxia-Inducible Factor (HIF inhibitor). The invention also relates to inducing acute myeloid leukemia remission using the HIF inhibitor. The invention further relates to inhibiting a maintenance or survival function of a cancer stem cell (CSC) using the HIF inhibitor.
    Type: Grant
    Filed: March 3, 2017
    Date of Patent: January 30, 2018
    Assignee: ONCOIMMUNE, INC.
    Inventors: Yang Liu, Yin Wang, Yan Liu, Sami N. Malek, Pan Zheng
  • USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS
    Publication number: 20170239315
    Abstract: The present invention relates to treating a hematologic cancer using a Hypoxia-Inducible Factor (HIF inhibitor). The invention also relates to inducing acute myeloid leukemia remission using the HIF inhibitor. The invention further relates to inhibiting a maintenance or survival function of a cancer stem cell (CSC) using the HIF inhibitor.
    Type: Application
    Filed: March 3, 2017
    Publication date: August 24, 2017
    Inventors: Yang Liu, Yin Wang, Yan Liu, Sami N. Malek, Pan Zheng
  • Uses of hypoxia-inducible factor inhibitors
    Patent number: 9623070
    Abstract: The present invention relates to treating a hematologic cancer using a Hypoxia-Inducible Factor (HIF inhibitor). The invention also relates to inducing acute myeloid leukemia remission using the HIF inhibitor. The invention further relates to inhibiting a maintenance or survival function of a cancer stem cell (CSC) using the HIF inhibitor.
    Type: Grant
    Filed: August 11, 2016
    Date of Patent: April 18, 2017
    Assignee: Oncolmmune, Inc.
    Inventors: Yang Liu, Yin Wang, Yan Liu, Sami N. Malek, Pan Zheng
  • USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS
    Publication number: 20170035832
    Abstract: The present invention relates to treating a hematologic cancer using a Hypoxia-Inducible Factor (HIF inhibitor). The invention also relates to inducing acute myeloid leukemia remission using the HIF inhibitor. The invention further relates to inhibiting a maintenance or survival function of a cancer stem cell (CSC) using the HIF inhibitor.
    Type: Application
    Filed: August 11, 2016
    Publication date: February 9, 2017
    Inventors: Yang Liu, Yin Wang, Yan Liu, Sami N. Malek, Pan Zheng
  • Uses of hypoxia-inducible factor inhibitors
    Patent number: 9427413
    Abstract: The present invention relates to treating a hematologic cancer using a Hypoxia-Inducible Factor (HIF inhibitor). The invention also relates to inducing acute myeloid leukemia remission using the HIF inhibitor. The invention further relates to inhibiting a maintenance or survival function of a cancer stem cell (CSC) using the HIF inhibitor.
    Type: Grant
    Filed: June 25, 2010
    Date of Patent: August 30, 2016
    Assignee: OncoImmune, Inc.
    Inventors: Yang Liu, Yin Wang, Yan Liu, Sami N. Malek, Pan Zheng
  • USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS
    Publication number: 20120264697
    Abstract: The present invention relates to treating a hematologic cancer using a Hypoxia- Inducible Factor (HIF inhibitor). The invention also relates to inducing acute myeloid leukemia remission using the HIF inhibitor. The invention further relates to inhibiting a maintenance or survival function of a cancer stem cell (CSC) using the HIF inhibitor.
    Type: Application
    Filed: June 25, 2010
    Publication date: October 18, 2012
    Applicant: ONCOIMMUNE INC.
    Inventors: Yang Liu, Yin Wang, Yan Liu, Sami N. Malek, Pan Zheng